S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
Secure your stake in the Smart Home industry. (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
Secure your stake in the Smart Home industry. (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
Secure your stake in the Smart Home industry. (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
Secure your stake in the Smart Home industry. (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable

Dynatronics Stock Price, News & Analysis (NASDAQ:DYNT)

$0.58
+0.03 (+5.46%)
(As of 11/28/2023 ET)
Compare
Today's Range
$0.53
$0.60
50-Day Range
$0.50
$0.77
52-Week Range
$0.47
$2.73
Volume
33,026 shs
Average Volume
19,275 shs
Market Capitalization
$2.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.80

Dynatronics MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
555.4% Upside
$3.80 Price Target
Short Interest
Healthy
1.82% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.93mentions of Dynatronics in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.64) to ($0.37) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.85 out of 5 stars


DYNT stock logo

About Dynatronics Stock (NASDAQ:DYNT)

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

DYNT Stock Price History

DYNT Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Here's what to expect from Dynatronics's earnings
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
What Wall Street expects from Dynatronics's earnings
Dynatronics Corporation Announces New Credit Facility
See More Headlines
Receive DYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dynatronics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/28/2023
Today
11/28/2023
Next Earnings (Estimated)
2/08/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DYNT
Employees
154
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$3.80
High Stock Price Target
$3.80
Low Stock Price Target
$3.80
Potential Upside/Downside
+555.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-4,970,000.00
Pretax Margin
-12.63%

Debt

Sales & Book Value

Annual Sales
$40.61 million
Book Value
$2.19 per share

Miscellaneous

Free Float
4,119,000
Market Cap
$2.63 million
Optionable
Not Optionable
Beta
0.32

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Brian D. Baker (Age 56)
    CEO, President & Director
    Comp: $273k
  • Mr. Gabe Ellwein
    Chief Financial Officer
  • Mr. Mike Withers
    Chief Information Officer














DYNT Stock Analysis - Frequently Asked Questions

Should I buy or sell Dynatronics stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dynatronics in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DYNT, but not buy additional shares or sell existing shares.
View DYNT analyst ratings
or view top-rated stocks.

What is Dynatronics' stock price target for 2024?

1 brokers have issued 1 year price targets for Dynatronics' stock. Their DYNT share price targets range from $3.80 to $3.80. On average, they expect the company's stock price to reach $3.80 in the next year. This suggests a possible upside of 555.4% from the stock's current price.
View analysts price targets for DYNT
or view top-rated stocks among Wall Street analysts.

How have DYNT shares performed in 2023?

Dynatronics' stock was trading at $1.9505 at the start of the year. Since then, DYNT shares have decreased by 70.3% and is now trading at $0.5798.
View the best growth stocks for 2023 here
.

Are investors shorting Dynatronics?

Dynatronics saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 57,800 shares, an increase of 549.4% from the October 31st total of 8,900 shares. Based on an average daily trading volume, of 25,300 shares, the days-to-cover ratio is currently 2.3 days. Approximately 1.8% of the shares of the company are short sold.
View Dynatronics' Short Interest
.

When is Dynatronics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024.
View our DYNT earnings forecast
.

How were Dynatronics' earnings last quarter?

Dynatronics Co. (NASDAQ:DYNT) posted its quarterly earnings data on Thursday, September, 28th. The medical equipment provider reported ($0.63) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.34) by $0.29. The medical equipment provider had revenue of $8.44 million for the quarter, compared to the consensus estimate of $8.04 million. Dynatronics had a negative net margin of 12.66% and a negative trailing twelve-month return on equity of 46.68%. During the same period in the prior year, the business earned ($0.50) earnings per share.

When did Dynatronics' stock split?

Dynatronics shares reverse split before market open on Tuesday, January 31st 2023. The 1-5 reverse split was announced on Tuesday, January 31st 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 31st 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

What guidance has Dynatronics issued on next quarter's earnings?

Dynatronics updated its FY 2024 earnings guidance on Thursday, September, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $34.00 million-$37.00 million, compared to the consensus revenue estimate of $35.50 million.

What other stocks do shareholders of Dynatronics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dynatronics investors own include Biocept (BIOC), Nuwellis (CHFS), Heat Biologics (HTBX), Bionano Genomics (BNGO), iBio (IBIO), Alto Ingredients (PEIX), Sorrento Therapeutics (SRNE), Palatin Technologies (PTN) and Electrameccanica Vehicles (SOLO).

How do I buy shares of Dynatronics?

Shares of DYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:DYNT) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -